LC16m8 vaccine (Q95615): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Verification Status | |||
Concluído | |||
| Property / Verification Status: Concluído / rank | |||
Normal rank | |||
Revision as of 11:25, 16 August 2026
Mpox vaccine with WHO Emergency Use Listing since August 2024. LC16 (KMB)” (LC16m8 vaccine) is indicated for active immunization to prevent mpox disease and the vaccine is given by multiple puncture vaccination using bifurcated needle. It is given as a one dose vaccine from one year of age.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_428806626 |
||
| English | LC16m8 vaccine |
Mpox vaccine with WHO Emergency Use Listing since August 2024. LC16 (KMB)” (LC16m8 vaccine) is indicated for active immunization to prevent mpox disease and the vaccine is given by multiple puncture vaccination using bifurcated needle. It is given as a one dose vaccine from one year of age. |
Statements
CID11:ID_428806626
0 references
dki-india-ID_428806626
0 references
Concluído
0 references
